Back

Cross-phenotype associations between Alzheimer's Disease and its comorbidities may provide clues to progression

Moore, A.; Ritchie, M. D.

2023-11-07 genetic and genomic medicine
10.1101/2023.11.06.23297993 medRxiv
Show abstract

Alzheimers disease (AD) is the most prevalent neurodegenerative disease worldwide, with one in nine people over the age of 65 living with the disease in 2023. In this study, we used a phenome wide association study (PheWAS) approach to identify cross-phenotype associations between previously identified genetic AD and for electronic health record (EHR) diagnoses from the UK Biobank (UKBB) (n=361,194 of European ancestry) and the eMERGE Network (n=105,108 of diverse ancestry). Based on 497 previously identified AD-associated variants from the Alzheimers Disease Variant Portal (ADVP), we found significant associations primarily in immune and cardiac related diseases in our PheWAS. Replicating variants have widespread impacts on immune genes in diverse tissue types. This study demonstrates the potential of using the PheWAS strategy to improve our understanding of AD progression as well as identify potential drug repurposing opportunities for new treatment and disease prevention strategies.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above